Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingjun Zhou

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
Cancer|August 21, 2015
Population-based study of the effect of gene expression profiling on adjuvant chemotherapy use in breast cancer patients under the age of 65 yearsArnold L Potosky, Suzanne C O'Neill, Claudine Isaacs, et al.
Optics Express|November 22, 2024
Multi-kilometer visible light communication utilizing nonlinearity-adaptive hybrid probabilistic-geometric shapingFang Dong, Zhiteng Luo, Zengyi Xu, et al.
Vaccine|January 26, 2021
Low dose recombinant full-length circumsporozoite protein-based Plasmodium falciparum vaccine is well-tolerated and highly immunogenic in phase 1 first-in-human clinical testingDeAnna J Friedman-Klabanoff, Andrea A Berry, Mark A Travassos, et al.
Cancer Causes & Control : CCC|July 1, 2018
Risk of diabetes complications among those with diabetes receiving androgen deprivation therapy for localized prostate cancerMarie C Bradley, Yingjun Zhou, Andrew N Freedman, et al.
Translational Behavioral Medicine|February 10, 2018
Quality of life among men with low-risk prostate cancer during the first year following diagnosis: the PREPARE prospective cohort studyKathryn L Taylor, George Luta, Richard M Hoffman, et al.
World Journal of Urology|April 17, 2016
Use of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancerAlex Z Fu, Huei-Ting Tsai, Reina Haque, et al.
The Journal of Urology|December 24, 2016
Mortality and Androgen Deprivation Therapy as Salvage Treatment for Biochemical Recurrence after Primary Therapy for Clinically Localized Prostate CancerAlex Z Fu, Huei-Ting Tsai, Reina Haque, et al.
Nature Communications|March 11, 2025
Edge-guided inverse design of digital metamaterial-based mode multiplexers for high-capacity multi-dimensional optical interconnectAolong Sun, Sizhe Xing, Xuyu Deng, et al.
Nature Communications|July 2, 2025
Seamless optical cloud computing across edge-metro network for generative AISizhe Xing, Aolong Sun, Chengxi Wang, et al.
The Lancet. HIV|February 10, 2020
Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trialPunnee Pitisuttithum, Sorachai Nitayaphan, Suwat Chariyalertsak, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Cancer|August 21, 2015
Population-based study of the effect of gene expression profiling on adjuvant chemotherapy use in breast cancer patients under the age of 65 yearsArnold L Potosky, Suzanne C O'Neill, Claudine Isaacs, et al.
Optics Express|November 22, 2024
Multi-kilometer visible light communication utilizing nonlinearity-adaptive hybrid probabilistic-geometric shapingFang Dong, Zhiteng Luo, Zengyi Xu, et al.
Vaccine|January 26, 2021
Low dose recombinant full-length circumsporozoite protein-based Plasmodium falciparum vaccine is well-tolerated and highly immunogenic in phase 1 first-in-human clinical testingDeAnna J Friedman-Klabanoff, Andrea A Berry, Mark A Travassos, et al.
Cancer Causes & Control : CCC|July 1, 2018
Risk of diabetes complications among those with diabetes receiving androgen deprivation therapy for localized prostate cancerMarie C Bradley, Yingjun Zhou, Andrew N Freedman, et al.
Translational Behavioral Medicine|February 10, 2018
Quality of life among men with low-risk prostate cancer during the first year following diagnosis: the PREPARE prospective cohort studyKathryn L Taylor, George Luta, Richard M Hoffman, et al.
World Journal of Urology|April 17, 2016
Use of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancerAlex Z Fu, Huei-Ting Tsai, Reina Haque, et al.
The Journal of Urology|December 24, 2016
Mortality and Androgen Deprivation Therapy as Salvage Treatment for Biochemical Recurrence after Primary Therapy for Clinically Localized Prostate CancerAlex Z Fu, Huei-Ting Tsai, Reina Haque, et al.
Nature Communications|March 11, 2025
Edge-guided inverse design of digital metamaterial-based mode multiplexers for high-capacity multi-dimensional optical interconnectAolong Sun, Sizhe Xing, Xuyu Deng, et al.
Nature Communications|July 2, 2025
Seamless optical cloud computing across edge-metro network for generative AISizhe Xing, Aolong Sun, Chengxi Wang, et al.
The Lancet. HIV|February 10, 2020
Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trialPunnee Pitisuttithum, Sorachai Nitayaphan, Suwat Chariyalertsak, et al.
Pageof 15